MANAGEMENT OF HEADACHE IN PATIENTS WITH NON-TRAUMATIC SUBARACHNOID HEMORRHAGE


Cite item

Full Text

Abstract

This review of the literature is devoted to the current state of the problem of management of headache in patients with non-traumatic subarachnoid hemorrhage (NSAH). This pathology is associated with severe and prolonged headache. Despite the huge amount of references on subarachnoid hemorrhage, a little attention is paid to headache in this pathology, so it remains largely unexplored. The article presents data on the epidemiology of the syndrome, possible mechanisms of occurrence, diagnostic methods. Details of the advantages and disadvantages of drugs for anesthesia, available in the arsenal of the clinician at the moment. The results of many previously published studies are diametrically opposed, which does not facilitate the choice of tactics for effective treatment and prevention of complications. The article also identifies the problems, the solution of which, possibly, will lead to an improvement in the results of treatment of SAH and further the quality of life of the patients. The lack of evidance data on the subject suggests that the research is relevant.

About the authors

I. R Ganeeva

Kazan’ State Medical University

420012, Kazan’, Russian Federation

References

  1. Крылов В.В., ред. Хирургия аневризм головного мозга. В трех томах: т. 1. Москва, 2011
  2. Rabinstein A.A., Lanzino G., Wijdicks E.F. Multidisciplinary management and emerging therapeutic strategies in aneurysmal subarachnoid haemorrhage. Lancet Neurol. 2010; 9 (5): 504-19
  3. Mahon P., Smith B., Browne J., Hawkshaw S., McEvoy L., Greene K., Rowan C., Markey F. Effective headache management in the aneurysmal subarachnoid patient: a literature review. British Journal of Neuroscience Nursing. 2012; 8 (2): 89-93.
  4. Svensson I., Sjostrom B., Haljamae H. Influence of expectations and actual pain experiences on satisfaction with postoperative pain management. Eur. J. Pain. 2001; 5 (2): 125-33.
  5. Talke P.O., Gelb A.W. Postcraniotomy pain remains a real headache. Eur. J. Anaesthesiol. 2005; 22: 324-6.
  6. Landtblom A.M., Fridriksson S., Boivie J., Hillman J., Johansson G., Johansson I. Sudden onset headache: A prospective study of features, incidence and causes. Cephalalgia. 2002; 22: 354-60.
  7. Ducros A., Bousser M.G. Thunderclap headache. BMJ. 2013; 346:e 8557.
  8. Naganuma M., Fujioka S., Inatomi Y. et al. Clinical characteristics of subarachnoid hemorrhage with or without headache. J Stroke Cerebrovasc. Dis. 2008; 17: 334-9.
  9. Linn F.H., Rinkel G.J., Algra A., van Gijn J. Headache characteristics in subarachnoid haemorrhage and benign thunderclap headache. J. Neurol. Neurosurg. Psychiatry. 1998; 65: 791-3.
  10. Polmear A. Sentinel headaches in aneurysmal subarachnoid haemorrhage: what is the true incidence? A systematic review. Cephalalgia. 2003; 23: 935-41.7.
  11. Linn F.H., Wijdicks E.F., van der Graaf Y., Weerdesteynvan Vliet F.A., Bartelds A.I., van Gijn J. Prospective study of sentinel headache in aneurysmal subarachnoid haemorrhage. Lancet. 1994; 344: 590-3.
  12. Dodick D.W. Thunderclap headache. J Neurol Neurosurg Psychiatry. 2002; 72: 6
  13. Togha M., Sahraian M.A., Khorram M., Khashayar P. Warning Signs and Symptoms of Subarachnoid Hemorrhage. Southern Medical Journal. 2009; 102-1.
  14. Jakobsson K.E., Saveland H., Hillman J. et al. Warning leak and management outcome in aneurysmal subarachnoid hemorrhage. J neurosurg. 1996; 85: 995-9.
  15. Bassi P., Bandera R., Loiero M. et al. Warning signs in subarachnoid hemorrhage: a cooperative study. Acta Neurol. Scand. 1991; 84: 277-81.
  16. Dhakal L.P., Harriott A.M., Capobianco D.J., D. Freeman W.D. Headache and Its Approach in Today’s NeuroIntensive Care Unit. Neurocritical Care. 2016 Mar; 21: 1-15.
  17. Dhakal L.P., Hodge D.O., Nagal J. et al. Safety and Tolerability of Gabapentin for Aneurysmal Subarachnoid Hemorrhage (SAH) Headache and Meningismus. Neurocritical Care. 2015; 22: 414-21.
  18. Steiner T., Juvela S., Unterberg A. et al. European Stroke Organization guidelines for the management of intracranial aneurysms and subarachnoid haemorrhage. Cerebrovasc. Dis. 2013; 35: 93-112.
  19. Connolly E.S. Jr., Rabinstein A.A., Carhuapoma J.R. et al. Guidelines for the management of aneurysmal subarachnoid hemorrhage: A guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2012; 43: 1711-37.
  20. Breivik H., Borchgrevink P.C., Allen S.M. et al. Assessment of pain. Br. J. Anaesth. 2008; 101: 17-24.
  21. Barr J., Fraser G.L., Puntillo K. et al. Clinical practice guidelines for the management of pain, agitation, and delirium in adult patients in the intensive care unit. Crit Care Med. 2013; 41: 263-306.
  22. Stites M. Observational pain scales in critically ill adults. Crit. Care Nurs. 2013; 33: 68-78.
  23. Бахтадзе М.А., Болотов Д.А., Кузьминов К.О. и др. Лингвистическая адаптация второй сокращенной формы Мак-Гилловского болевого опросника. Российский журнал боли. 2015; 2: 26-9.
  24. Steiner T., Juvela S., Unterberg A. et al. European Stroke Organization guidelines for the management of intracranial aneurysms and subarachnoid haemorrhage. Cerebrovasc. Dis. 2013; 35: 93-112.
  25. Albanese J., Viviand X., Potie F., Rey M., Alliez B., Martin C. Sufentanil, fentanyl, and alfentanil in head trauma patients: a study on cerebral hemodynamics. Crit. Care Med. 1999; 27: 407-11.
  26. Rao T.L., Mummaneni N., El-Etr A.A. Convulsions: an unusual response to intravenous fentanyl administration. Anesth. Analg. 1982; 61: 1020-1.
  27. Futier E., Chanques G., Cayot Constantin S., et al. Influence of opioid choice on mechanical ventilation duration and ICU length of stay. Minerva Anestesiol. 2012; 78: 46-53.
  28. Cammarano W.B., Pittet J.F., Weitz S., Schlobohm R.M., Marks J.D. Acute withdrawal syndrome related to the administration of analgesic and sedative medications in adult intensive care unit patients. Crit. Care Med. 1998; 26: 676-84.
  29. Peng P.W., Sandler A.N. A review of the use of fentanyl analgesia in the management of acute pain in adults. Anesthesiology. 1999; 90: 576-99.
  30. Murphy D.B., Sutton J.A., Prescott L.F., Murphy M.B. Opioid- induced delay in gastric emptying: a peripheral mechanism in humans. Anesthesiology. 1997; 87: 765-70.
  31. Reaven N.L., Lovett J.E., Funk S.E. Brain injury and fever: hospital length of stay and cost outcomes. J. Intensive Care Med. 2009; 24: 131-9.
  32. Ma X.D., Hauerberg J., Pedersen D.B., Juhler M. Effects of morphine on cerebral blood flow autoregulation CO2-reactivity in experimental subarachnoid hemorrhage. J. Neurosurg. Anesthesiol. 1999; 11: 264-72.
  33. Roberts G. A review of the efficacy and safety of opioid analgesics post-craniotomy. Nurs. Crit Care. 2004; 9 (6): 277-83.
  34. Rinkel G.J., Klijn C.J. Prevention and treatment of medical and neurological complications in patients with aneurysmal subarachnoid haemorrhage. Pract. Neurol. 2009; 9 (4): 195-209.
  35. Binhas M., Walleck P., El Bitar N. et al. Pain management in subarachnoid haemorrhage: a survey of French analgesic practices. Ann. Fr. Anesth. Reanim. 2006; 25 (9): 935-9.
  36. Randell T., Niemelä M., Kyttä J. et al. Principles of neuroanesthesia in aneurysmal subarachnoid hemorrhage: The Helsinki experience. Surg. Neurol. 2006; 66 (4): 382-8.
  37. Niemi T.Tanskanen P., Taxell Ch., Juvela S., Randell T., Rosenberg P.Effects of nonsteroidal anti-inflammatory drugs on hemostasis in patients with aneurysmal subarachnoid hemorrhage. J. Neurosurg. Anesthesiol. 1999; 11 (3): 188-94.
  38. Muroi C., Hugelshofer M., Seule M.A., Keller E. The impact of nonsteroidal anti-inflammatory drugs on inflammatory response after aneurysmal subarachnoid hemorrhage. Neurocritical Care. 2014; 20 (2): 240-6.
  39. Elia N., Lysakowski C., Tramer M.R. Does multimodal analgesia with acetaminophen, nonsteroidal antiinflammatory drugs, or selective cyclooxygenase-2 inhibitors and patient-controlled analgesia morphine offer advantages over morphine alone? Meta-analyses of randomized trials. Anesthesiology. 2005; 103 (6): 1296-304.
  40. Remy C., Marret E., Bonnet F. Effects of acetaminophen on morphine side-effects and consumption after major surgery: meta- analysis of randomized controlled trials. Br. J. Anaesth. 2005; 94 (4): 505-13.
  41. Maund E., McDaid C., Rice S., Wright K., Jenkins B., Woolacott N. Paracetamol and selective and non-selective non-steroidal anti-inflammatory drugs for the reduction in morphine-related side-effects after major surgery: a systematic review. Br. J. Anaesth. 2011; 106 (3): 292-7.
  42. Memis D., Inal M.T., Kavalci G., Sezer A., Sut N. Intravenous paracetamol reduced the use of opioids, extubation time, and opioid- related adverse effects after major surgery in intensive care unit. J. Crit. Care. 2010; 25 (3): 458-62.
  43. Bertin P., Keddad K., Jolivet-Landreau I. Acetaminophen as symptomatic treatment of pain from osteoarthritis. Joint Bone Spine. 2004; 71 (4): 266-74.
  44. Cheng J.K., Chiou L.C. Mechanisms of the antinociceptive action of gabapentin. J. Pharmacol. Sci. 2006; 100: 471-86.
  45. Fink K., Kooley D.J., Meder W.P., et al. Inhibition of neuronal Ca (2+) influx by gabapentin and pregabalin in the human neocortex. Neuropharmacology. 2002; 42: 229-36.
  46. Abdel-Salam O.M., Sleem A.A. Study of the analgesic, anti- inflammatory, and gastric effects of gabapentin. Drug Discov. Ther. 2009; 3: 18-26.
  47. Dhakal L.P., Hodge D.O., Nagal J. et al. Safety and Tolerability of Gabapentin for Aneurysmal Subarachnoid Hemorrhage (SAH) Headache and Meningismus. Neurocritical Care. 2015; 22: 414-21.
  48. Dorhout Mees S.M. MASH-II study group. Magnesium in aneurysmal subarachnoid hemorrhage (MASH II) phase III clinical trial. International Journal of Stroke. 2008; 3: 63e5.
  49. Dorhout Mees S.M., Bertens D., H.B. van der Worp, Rinkel G.J.E., W.M. van den Bergh. Magnesium and headache after aneurysmal subarachnoid haemorrhage. J Neuro. Neurosurg. Psychiatry. 2010; 81: 490-3.
  50. Rinkel G.J., Feigin V.L., Algra A., Vermeulen M., van Gijn J. Calcium antagonists for aneurysmal subarachnoid haemorrhage. Cochrane Database Syst. Rev. (Online) 2002: CD000277.
  51. Liu G.J., Luo J., Zhang L.P. et al. Meta-analysis of the effectiveness and safety of prophylactic use of nimodipine in patients with an aneurysmal subarachnoid haemorrhage. CNS Neurol. Disord. Drug Targets. 2011; 10: 834-44.
  52. Glisic E.K. Inadequacy of headache management after subarachnoid hemorrhage. American Journal of Critical Care. March. 2016; 25 (2): 136-43.
  53. Canhão P., Ferro J.M., Pinto A.N., MeloT.P., Campos J.G. Perimesencephalic and nonperimesencephalic subarachnoid hemorrhages with negative angiograms. Acta Neurochir. 1995; 132 (1-3): 14-9.
  54. Singh M., Guth J.C., Liotta E. et al. Predictors of 30-day readmission after subarachnoid hemorrhage. Neurocritical Care. 2013; 19 (3): 306-10.
  55. Greebe P., Rinkel G.J. Life expectancy after perimesencephalic subarachnoid hemorrhage. Stroke. 2007; 38 (4):1222-4.
  56. Ogden J., UtleyT., Mee E. Neurological and psychological outcome 4 to 7 years after subarachnoid hemorrhage. Neurosurgery. 1997; 41 (1): 25-34.
  57. Marquardt G., NiebauerT., Schick U., Lorenz R. Long term follow up after perimsencephalic subarachnoid haemorrhage. J. Neurol. Neurosurg. Psychiatry. 2000; 69 (1): 127-30.
  58. Pain terms: A list with definitions and notes on usage. Recommended by the IASP subcommittee on taxonomy. Pain.1979; 6: 249.
  59. Bourbonnais F.F., Perreault A., Bouvette M. Introduction of a pain and symptom assessment tool in the clinical setting: lessons learned. J. Nurs. Manag. 2004; 12 (3): 194-200.
  60. Whelan C.T., Jin L., Meltzer D. Pain and satisfaction with pain control in hospitalized medical patients: no such thing as low risk. Arch. Intern. Med. 2004; 164 (2): 175-80.
  61. Hader C.F., Guy J. Your hand in pain management. Nurs. Manage. 2004; 35 (11): 21-7.
  62. Leith B. Pharmacological management of pain after intracranial surgery. J. Neurosci. Nurs. 1998; 30 (4): 220-4.
  63. McLafferty E., Farley A. Assessing pain in patients. Nurs. Stand. 2008; 22 (25): 42-6.

Copyright (c) 2017 Eco-Vector


 


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies